Drugs List

Therapeutic Indications

Uses

For the treatment of contact dermatitis, atopic dermatitis, senile pruritis, ichthyosis, and related dry skin conditions.

Administration

For topical external use. Should always be used with water, either added to the water or applied to wet skin.

Contraindications

Hypersensitivity to lanolin

Precautions and Warnings

The patient should be advised that the bath may become slippery and care should be taken to avoid slipping.

Discontinue treatment if a rash or skin irritation occurs.

Contains acetylated wool alcohols

Pregnancy and Lactation

Pregnancy

Safety not established, but the product has been in wide use for many years without ill consequence.

The use of all medication in pregnancy should be avoided whenever possible; particularly in the first trimester. Non-drug treatments should also be considered. When essential, a medication with the best safety record over time should be chosen, employing the lowest effective dose for the shortest possible time. Polypharmacy should be avoided. Teratogens taken in the pre-embryonic period, often quoted as lasting until 14 to 17 days post-conception, are believed to have an all-or-nothing effect. Where drugs have a short half-life, and when the date of conception is certain, this may allow women to be reassured where drug exposure has occurred within this time frame. Further advice may be available from the UK National Teratology Information Service (NTIS) and through ToxBase, available via password on the internet ( www.toxbase.org ) or if this is unavailable at the backup site ( www.toxbasebackup.org ).

Lactation

Safety not established, but the product has been in wide use for many years without ill consequence.

Neonates, infants born prematurely, those with low birth weight, those with an unstable gastrointestinal function or who have serious illnesses may require special consideration. For any infant, if a drug is prescribed to the nursing mother, it should be at the lowest practical dose and for the shortest time. When drug administration is unavoidable and breastfeeding is to continue, minimisation of exposure of the infant to the drug may sometimes be achieved by timing the maternal doses to just after a feeding episode. Infants exposed to drugs via breast milk should be monitored for unusual signs or symptoms. Interactions between the drug received by the infant from the mother's milk and medication prescribed for the infant should also be considered, for example, when the drug given to the infant may prevent metabolism of the drug received via breast milk.
Specialist advice is available from the UK Drugs in Lactation Advisory Service at https://www.midlandsmedicines.nhs.uk/content.asp?section=6&subsection=17&pageIdx=1

Side Effects

Hypersensitivity reactions
Skin irritation
Rash

Presentation

Liquid bath additive containing light liquid paraffin 63.4% w/w and acetylated wool alcohols 5% w/w

Drugs List

Therapeutic Indications

Uses

For the treatment of contact dermatitis, atopic dermatitis, senile pruritis, ichthyosis, and related dry skin conditions.

Dosage

If possible, especially in the case of extensive areas of dry skin, the preparation should be used as a bath additive, ensuring complete coverage by immersion.

Adults

Children

Administration

For topical external use. Should always be used with water, either added to the water or applied to wet skin.

Contraindications

Hypersensitivity to lanolin

Precautions and Warnings

The patient should be advised that the bath may become slippery and care should be taken to avoid slipping.

Discontinue treatment if a rash or skin irritation occurs.

Contains acetylated wool alcohols

Pregnancy and Lactation

Pregnancy

Safety not established, but the product has been in wide use for many years without ill consequence.

The use of all medication in pregnancy should be avoided whenever possible; particularly in the first trimester. Non-drug treatments should also be considered. When essential, a medication with the best safety record over time should be chosen, employing the lowest effective dose for the shortest possible time. Polypharmacy should be avoided. Teratogens taken in the pre-embryonic period, often quoted as lasting until 14 to 17 days post-conception, are believed to have an all-or-nothing effect. Where drugs have a short half-life, and when the date of conception is certain, this may allow women to be reassured where drug exposure has occurred within this time frame. Further advice may be available from the UK National Teratology Information Service (NTIS) and through ToxBase, available via password on the internet ( www.toxbase.org ) or if this is unavailable at the backup site ( www.toxbasebackup.org ).

Lactation

Safety not established, but the product has been in wide use for many years without ill consequence.

Neonates, infants born prematurely, those with low birth weight, those with an unstable gastrointestinal function or who have serious illnesses may require special consideration. For any infant, if a drug is prescribed to the nursing mother, it should be at the lowest practical dose and for the shortest time. When drug administration is unavoidable and breastfeeding is to continue, minimisation of exposure of the infant to the drug may sometimes be achieved by timing the maternal doses to just after a feeding episode. Infants exposed to drugs via breast milk should be monitored for unusual signs or symptoms. Interactions between the drug received by the infant from the mother's milk and medication prescribed for the infant should also be considered, for example, when the drug given to the infant may prevent metabolism of the drug received via breast milk.
Specialist advice is available from the UK Drugs in Lactation Advisory Service at https://www.midlandsmedicines.nhs.uk/content.asp?section=6&subsection=17&pageIdx=1

Effects on Ability to Drive and Operate Machinery

None

Counselling

The patient should be advised that the bath may become slippery and care should be taken to avoid slipping.

Side Effects

Hypersensitivity reactions
Skin irritation
Rash

Overdosage

It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.

The following number will direct the caller to the relevant local centre (0844) 892 0111

Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( https://www.toxbase.org/ ) or if this is unavailable at the backup site ( https://www.TOXBASEbackup.org/ ).

Shelf Life and Storage

No special requirements

Reference Sources

Summary of Product Characteristics: Oilatum Emollient. Stiefel Laboratories (UK) Ltd. Revised April 2016.
Summary of Product Characteristics: Oilatum Junior. Stiefel Laboratories (UK) Ltd. Revised April 2016.

NICE Evidence Services Available at: www.nice.org.uk Last accessed: 22 August 2017